Donzakimig

Approval Year

Name

Type

Language

Donzakimig

Official Name

English

Fused G1(VH-CH1-h)-scFv heavy-kappa heavy chain humanized (1-486) [G1(VH-CH1-h) anti-IL22 humanized (1-222) [VH (Homo sapiens IGHV3-23*04 (83.7%) -(IGHD) -IGHJ5*02 (100%), CDR-IMGT [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo sapiens IGHG1*01 CH1-h, G1m1

Common Name

English

mmunoglobulin G1(VH-CH1-h)-scFv_L-kappa-scFv, anti-[Homo sapiens IL22 (interleukin 22, IL-22, ILTIF, IL-TIF)], anti-[Homo sapiens IL13 (interleukin 13, IL-13)] and anti-[Homo sapiens ALB (albumin, human serum albumin, HAS)], humanized, trispecific, triva

Common Name

English

donzakimig [INN]

Common Name

English

Immunoglobulin G1, anti-(human interleukin 22) (human-Oryctolagus cuniculus γ1-chain N-terminal fragment) fusion protein with peptide linker (SGGGGSGGGGS) fusion protein with immunoglobulin anti-(human serum albumin) (human-Oryctolagus cuniculus single-

Common Name

English

Code System Code Type Description

INN

12679

Created by admin on Sat Dec 16 18:10:53 GMT 2023 , Edited by admin on Sat Dec 16 18:10:53 GMT 2023

PRIMARY

FDA UNII

H239R928TY

Created by admin on Sat Dec 16 18:10:53 GMT 2023 , Edited by admin on Sat Dec 16 18:10:53 GMT 2023

PRIMARY

ACTIVE MOIETY


					H239R928TY

Donzakimig